Health Care Equipment & Services

Medical Marijuana, Inc. pioneers global CBD research, offering therapeutic oils and tinctures while driving innovation in healthcare.

Dexcom’s CGM tech proves reliable in a Swiss insulin‑patch pilot, delivering accurate real‑time glucose data with no failures – a key step for integrated diabetes care.

Chemed Corporation secures a $450 million revolving credit line, boosting liquidity, flexibility for acquisitions and growth in healthcare and restoration services.

Share‑holding changes at German health‑care firm Eckert & Ziegler SE boost European distribution, improve liquidity and set the stage for stronger governance and growth.

Revenio Group Oyj’s €250 m Visionix acquisition aims to become a turnkey eye‑care leader, doubling its TAM, boosting EBITDA and expanding OCT expertise by Q2 2026.

Abbott Laboratories faces a $53 million lawsuit over preterm infant formula, analyst price‑target shifts, and active institutional trading—what it means for investors.

Viromed Medical AG’s manager‑sale spurs a 4.9 % share rally, showcasing executive transparency and hinting at future upside.

iSpecimen’s new direct‑shipment model cuts biospecimen transit times by up to 85% and drove a 91% surge in its share price.

Virax Biolabs, a Nasdaq‑listed biotech, focuses on viral diagnostics, PPE and immunology‑based products, navigating tough markets while driving innovation in disease prevention and detection.

Bluejay Diagnostics enrolls 624 of 750 SYMON‑II trial patients, advancing the Symphony IL‑6 sepsis test toward regulatory approval and improved critical‑care outcomes.